New treatment for sepsis disappointing in childrenBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39156.609271.80 (Published 22 March 2007) Cite this as: BMJ 2007;334:608
Drotrecogin alfa, a recombinant human activated protein C, is a new treatment for severe sepsis. At least one trial has shown that it reduces mortality in adults, so researchers were “profoundly disappointed” to find that it may not work so well, if at …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial